Sort
15,842 grants matching “pancreatic cancer”
Cost Effectiveness of Germline Genetic Testing in Pancreatic Cancer
$252,164Mary Linton B Peters · Beth Israel Deaconess Medical Center · K08 · FY2024 · CA
Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment
$252,065Elise C. Kohn · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Enhanced CRAd for Pancreatic Cancer
$252,035David T Curiel · University Of Alabama At Birmingham · R01 · FY2006 · CA
Growth hormone and adult physiology
$252,000Rhonda D. Kineman · University Of Illinois At Chicago · R01 · FY2010 · DK
microRNAs as novel Biomarkers for Pancreatic Ductal Adenocarcinoma
$251,843Murray Korc · Dartmouth College · R21 · FY2008 · CA
BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer Variant Curation Expert Panels
$251,798Fergus Joseph Couch · Mayo Clinic Rochester · U24 · FY2023 · CA
Project 3: Role of the pancreatic fibroinflammatory microenvironment in obesity-promoted pancreatic cancer
$251,646Stephen J Pandol · University Of California Los Angeles · P01 · FY2021 · CA
Targeting Stroma to Improve Therapy of Pancreatic Adenocarcinoma
$251,616Yves Boucher · Massachusetts General Hospital · P01 · FY2015 · CA
Targeting Stroma to Improve Therapy of Pancreatic Adenocarcinoma
$251,616Yves Boucher · Massachusetts General Hospital · P01 · FY2016 · CA
MOLECULAR IMAGING CORE
$251,600Ralph Weissleder · University Of Tx Md Anderson Can Ctr · P01 · FY2015 · CA
Molecular Mechanisms and Application of Ah Receptor-MicroRNA Interactions
$251,424Stephen H Safe · Texas A&M University · R01 · FY2014 · CA
Molecular determinants of A-site mRNA cleavage during ribosome pausing
$251,391Christopher S. Hayes · University Of California Santa Barbara · R01 · FY2007 · GM
Core B: Liver Metastasis Resource Core (LMRC)
$251,389Edwin Melencio Posadas · Cedars-Sinai Medical Center · P01 · FY2021 · CA
SURVIVAL SIGNALING INHIBITORS AS CANCER DRUGS
$251,384Prolx Pharmaceuticals, Lp · R43 · FY2001 · CA
Regionalization of the Vertebrate Endoderm
$251,297Victoria E Prince · University Of Chicago · R01 · FY2006 · DK
Host genes controlling rodent protoparvovirus tissue and species tropism
$251,250Peter Tattersall · Yale University · R21 · FY2021 · AI
Impact of circadian disruption on pancreatic cancer development and progression
$251,250Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R21 · FY2023 · ES
Cost Effectiveness of Germline Genetic Testing in Pancreatic Cancer
$251,129Mary Linton B Peters · Beth Israel Deaconess Medical Center · K08 · FY2020 · CA
REGULATION OF PAR 4 BY ONCOGENIC RAS
$251,109University Of Kentucky · R01 · FY2002 · CA
Automated High Throughput Cryopreservation Using Microfluidics
$251,046Steven Francis Mullen · 21st Century Medicine, Inc. · R43 · FY2010 · RR
STRAP and Smad 7 Signaling in Colerectal Carcinomas
$251,038Vanderbilt University · R01 · FY2003 · CA
STRAP and Smad 7 Signaling in Colerectal Carcinomas
$251,038Vanderbilt University · R01 · FY2004 · CA
STRAP and Smad 7 Signaling in Colerectal Carcinomas
$251,038Vanderbilt University · R01 · FY2005 · CA
Mouse Model for Human Pancreatic Ductal Adenocarcinoma
$250,953Gloria Huei-Ting Su · Columbia University Health Sciences · R56 · FY2009 · CA
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$250,630Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI